Skip to main content
. 2019 May 3;20(9):2190. doi: 10.3390/ijms20092190
HCC Hepatocellular carcinoma
NAFLD Non-alcoholic fatty liver disease
NASH Non-alcoholic fatty liver steatohepatitis
AKT Protein Kinase B
MTT 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide
IC50 inhibitory concentration 50
PI Propidium Iodide